Pall Corporation, a global leader in filtration, separation and purification, is making significant investments in global production capacity to meet industry demands driven by COVID-19. These investments include additional production capacity at six existing manufacturing facilities in Europe and the United States, as well as a new manufacturing facility in the United States.

With these investments, Pall anticipates adding more than 1100 jobs globally now through the end of 2021 and will significantly increase output and reduce lead time for critical biopharmaceutical manufacturing solutions.

The demand for single use technology has increased in recent years and, with the global need for mass manufacturing of a COVID-19 vaccine, there is even more pressure on the existing supply chain. Pall’s new manufacturing facility will be in the United States and will focus primarily on single-use technology such as the Allegro™ single-use platform. These solutions support the rapid development and production of vaccines and therapeutics, including the COVID-19 vaccine.

Pall’s manufacturing facilities in Medemblik, Netherlands; Hoegaarden, Belgium; Bad Kreuznach, Germany; Ilfracombe, UK; Newquay, UK; Fajardo, Puerto Rico; and Pensacola, FL, U.S. will expand Pall’s capacity to produce and distribute single-use technology, media and breathing filters necessary to support the current global pandemic and future industry needs.

"Pall’s global capacity expansion will ensure our critical products are manufactured and delivered to our customers so people around the world have access to lifesaving vaccines and genes therapies," said Joseph Repp, President, Pall Life Sciences.

About Pall CorporationPall Corporation is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The Company’s engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation serves customers worldwide. For more information visit www.pall.com.

Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

Uso de RNA móviles para mejorar la asim...

El gen AtCDF3 promueve una mayor producción de az...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Destacadas

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

En nuestro post hablamos sobre este interesante tipo de célula del si...

Palobiofarma anuncia la finalización de...

by Palobiofarma

Palobiofarma S.L. se complace en anunciar la finalización del tratami...

Diapositiva de Fotos